ALEMBIC PHARMACEUTICALS
Back to Cashflow Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-164 Cr | ₹444 Cr | ₹-438 Cr | ₹-262 Cr | ₹-217 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-164 Cr |
| Mar2025 | ₹444 Cr |
| Mar2024 | ₹-438 Cr |
| Mar2023 | ₹-262 Cr |
| Mar2022 | ₹-217 Cr |
How is Cash Flow from Financing Activities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-164 Cr | Negative | |
| Mar2025 | ₹444 Cr | Positive | |
| Mar2024 | ₹-438 Cr | Negative | |
| Mar2023 | ₹-262 Cr | Negative | |
| Mar2022 | ₹-217 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹20,516.2 Cr | -0.3% | 32.1% | 14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -0.3% |
32.1% |
14.5% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses